Monitoring and profiling the characteristics of Novel Psychoactive Substances and their consumers in the context of the EU-MADNESS project
Abstract
The EC-funded EU-MADNESS project runs from April 2014 to March 2016, and involves 12 centres in five countries. The project’s objective is to develop integrated monitoring and profiling of Novel Psychoactive Substances (NPS) in Europe in order to prevent health harms and update relevant professionals. To achieve this, its aims are to: monitor, test, profile, and feed back into education and prevention knowledge relating to the types of NPS emerging, their associated characteristics and potential harms.Workstream (WS) 1 involves collecting a range of information from various sources relating to individuals who have reported using NPSs or died from such use. Recording of such data allows ascertainment of groups exposed to specific NPSs and their associated harms, helping to formulate improved approaches to identifying and recording deaths and ‘near misses’ linked to NPS use. Criteria for the selection of molecules to investigate in depth were developed; a key one is that of serious adverse health consequences including intoxications and deaths. Protocols for data-sharing, identification of types of data sources and types of data potentially available for use were agreed. Supply of death data on a ‘real-time’ basis is ongoing in Italy, Hungary and in the UK (Scotland and Northern Ireland; England & Wales in progress). Data from these reports and other information, test-purchases, etc. are informing the choice of compounds being investigated in WS2 and WS3.In WS2 computational…
Read the paper
Related studies
- The neurocircuitry of addiction: an overview
- Gender Differences in Human Brain: A Review
- Stratified medicine for mental disorders
- The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex
- Annual Research Review: DNA methylation as a mediator in the association between risk exposure and child and adolescent psychopathology
- Schizophrenia: The new etiological synthesis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.